Elanco Animal Health Incorporated (ELAN)
NYSE: ELAN · Real-Time Price · USD
25.71
+0.10 (0.39%)
At close: Feb 11, 2026, 4:00 PM EST
25.99
+0.28 (1.09%)
After-hours: Feb 11, 2026, 7:32 PM EST
Elanco Animal Health Market Cap
Elanco Animal Health has a market cap or net worth of $12.77 billion as of February 11, 2026. Its market cap has increased by 114.09% in one year.
Market Cap
12.77B
Enterprise Value
16.59B
1-Year Change
114.09%
Ranking
Category
Stock Price
$25.71
Market Cap Chart
Since September 20, 2018, Elanco Animal Health's market cap has decreased from $12.82B to $12.77B, a decrease of -0.38%. That is a compound annual growth rate of -0.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 12.72B | 13.17% |
| Dec 31, 2025 | 11.24B | 87.82% |
| Dec 31, 2024 | 5.99B | -18.47% |
| Dec 29, 2023 | 7.34B | 26.71% |
| Dec 30, 2022 | 5.79B | -56.84% |
| Dec 31, 2021 | 13.43B | -7.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 39.96B |
| United Therapeutics | 20.49B |
| Viatris | 18.58B |
| Neurocrine Biosciences | 13.70B |
| Regencell Bioscience Holdings | 13.21B |
| Dr. Reddy's Laboratories | 11.65B |
| Alkermes | 5.76B |
| Amneal Pharmaceuticals | 4.62B |